Volume | 9,112 |
|
|||||
News | - | ||||||
Day High | 8.60 | Low High |
|||||
Day Low | 8.1729 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Profound Medical Corporation | PROF | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
8.60 | 8.1729 | 8.60 | 8.29 | 8.485 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
126 | 9,112 | $ 8.26 | $ 75,300 | - | 7.11 - 15.49 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 200 | $ 8.30 | USD |
Profound Medical Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
239.3M | 21.37M | - | 7.2M | -28.57M | -1.34 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Profound Medical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PROF Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.80 | 8.92 | 7.50 | 8.05 | 44,457 | -0.51 | -5.80% |
1 Month | 7.79 | 8.92 | 7.30 | 7.84 | 28,675 | 0.50 | 6.42% |
3 Months | 8.50 | 9.4168 | 7.30 | 8.20 | 33,849 | -0.21 | -2.47% |
6 Months | 9.73 | 11.69 | 7.11 | 8.38 | 44,588 | -1.44 | -14.80% |
1 Year | 12.88 | 15.49 | 7.11 | 9.41 | 32,504 | -4.59 | -35.64% |
3 Years | 16.75 | 19.32 | 3.10 | 10.14 | 47,694 | -8.46 | -50.51% |
5 Years | 9.98 | 28.97 | 3.10 | 13.28 | 55,815 | -1.69 | -16.93% |
Profound Medical Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner. |